https://www.selleckchem.com/pr....oducts/FK-506-(Tacro
15, 95% CI 0.42-3.19, P = 0.79) or very late (OR 2.18, 95% CI 0.20-24.18; P = 0.53) ST. Moreover, there was no significant difference in the secondary endpoints, including MI (OR 1.11, 95% CI 0.72-1.71, P = 0.63), TVR (OR 1.31, 95% CI 0.82-2.07, P = 0.26), all-cause death (OR 1.03, 95% CI 0.61-1.75, P = 0.9 and major bleeding (OR 1.07, 95% CI 0.34-3.40, P = 0.9 between the two groups. Our study demonstrated that compared with long-term DAPT, short-term DAPT had no significant difference in the clinical outcomes of patien
Like
Comment
Share
